Researchers have unveiled advanced AI and machine learning models that enhance early diagnosis and prognosis prediction across various cancers. Notably, radiomics-based CT models differentiate liver tumors pre-surgery, and interpretable ML models forecast early liver metastasis in pancreatic cancer. Molecular profiling and multiomic analyses also offer nuanced patient stratification, paving the way for personalized oncology care and improved therapeutic outcomes.